The purpose of the study is to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Commonly referred to as "hay fever", it is characterized by sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
304
GSK Investigational Site
Austin, Texas, United States
GSK Investigational Site
Austin, Texas, United States
GSK Investigational Site
New Braunfels, Texas, United States
GSK Investigational Site
San Antonio, Texas, United States
Mean change from baseline over the entire treatment period in daily, reflective, total nasal symptom scores.
Mean change from baseline over the entire treatment period in the daily, reflective, total ocular symptom score.
Mean change from baseline over the entire treatment period in AM, pre-dose, instantaneous, total nasal symptom score.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.